Accredited Educational Activities

IMMERSIVE SIMULATION EXPERIENCE

Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization

This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.

New Insights on the Diagnosis and Treatment of Nonproliferative Diabetic Retinopathy

This enduring program targets critical issues in nonproliferative diabetic retinopathy (NPDR), including risk for retinopathy development and progression, how early treatment can help prevent progression to vision-threatening complications, and treatment strategies for NPDR. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in diabetes.

A Close Look at the Diagnosis and Treatment of Patients with Retinal Vascular Disease

This online activity targets healthcare gaps related to the diagnosis and management of diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO), impacting outcomes through risk stratification, diagnostic strategies, and treatment individualization with anti-VEGF agents.

CLICK ON STATES TO SEE LIVE ACTIVITIES

A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How

Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Scroll to Top

Search

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for diabetic retinopathy (DR) in patients with diabetes who have or are at risk for developing DR. Click on one of the options below to learn more about DR.

This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | Diabetic Retinopathy | All Rights Reserved | Website by Divigner
Menu

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX